BOTHELL, Wash., March 10, 2023 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies (“CGT”) and broader biopharma markets, today provided commentary on its current banking relationship…
